Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis
暂无分享,去创建一个
David Alland | James C Sacchettini | Catherine Vilchèze | Manzour H Hazbón | C. Vilchèze | Bing Chen | M. Hazbón | D. Alland | J. Sacchettini | W. Jacobs | Y. Av‐Gay | R. Colangeli | Yossef Av-Gay | Zhen Liu | William R Jacobs | Roberto Colangeli | Rodgoun Attarian | Zhen Liu | Bing Chen | Weijun Liu | Weijun Liu | Rodgoun Attarian | C. Vilchèze
[1] F. Kramer,et al. Genotypic Analysis of Mycobacterium tuberculosis in Two Distinct Populations Using Molecular Beacons: Implications for Rapid Susceptibility Testing , 2000, Antimicrobial Agents and Chemotherapy.
[2] G. Newton,et al. Mycothiol biochemistry , 2002, Archives of Microbiology.
[3] D. Clark,et al. Role of NAD in regulating the adhE gene of Escherichia coli , 1996, Journal of bacteriology.
[4] G. Newton,et al. A novel mycothiol-dependent detoxification pathway in mycobacteria involving mycothiol S-conjugate amidase. , 2000, Biochemistry.
[5] A. Telenti,et al. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level , 1997, Journal of clinical microbiology.
[6] G. Newton,et al. Characterization of Mycobacterium smegmatis mutants defective in 1-d-myo-inosityl-2-amino-2-deoxy-alpha-d-glucopyranoside and mycothiol biosynthesis. , 1999, Biochemical and biophysical research communications.
[7] C. Vilchèze,et al. Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid , 2006, Nature Medicine.
[8] H. Billman-Jacobe,et al. Inactivation of mshB, a key gene in the mycothiol biosynthesis pathway in Mycobacterium smegmatis. , 2003, Microbiology.
[9] R. Dubos,et al. Media for tubercle bacilli. , 1947, American review of tuberculosis.
[10] J C Sacchettini,et al. Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis. , 1995, Biochemistry.
[11] Wilming,et al. Spontaneous Formation of the Bioactive Form of the Tuberculosis Drug Isoniazid. , 1999, Angewandte Chemie.
[12] G. Newton,et al. N-Acetyl-1-d-myo-Inosityl-2-Amino-2-Deoxy-α-d-Glucopyranoside Deacetylase (MshB) Is a Key Enzyme in Mycothiol Biosynthesis , 2000, Journal of bacteriology.
[13] G. Newton,et al. The Glycosyltransferase Gene Encoding the Enzyme Catalyzing the First Step of Mycothiol Biosynthesis (mshA) , 2003, Journal of bacteriology.
[14] W. Schaefer,et al. Studies on isoniazid and tubercle bacilli. III. The isolation, drug-susceptibility, and catalase-testing of tubercle bacilli from isoniazid-treated patients. , 1954, American review of tuberculosis.
[15] P. Ortiz de Montellano,et al. The Antituberculosis Drug Ethionamide Is Activated by a Flavoprotein Monooxygenase* , 2002, The Journal of Biological Chemistry.
[16] L. Bekker,et al. Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[17] W. Jacobs,et al. New use of BCG for recombinant vaccines , 1991, Nature.
[18] T. Weisbrod,et al. NADH Dehydrogenase Defects Confer Isoniazid Resistance and Conditional Lethality in Mycobacterium smegmatis , 1998, Journal of bacteriology.
[19] G. Middlebrook. Isoniazid-resistance and catalase activity of tubercle bacilli; a preliminary report. , 1954, American review of tuberculosis.
[20] G. Bai,et al. Worldwide Emergence of Extensively Drug-resistant Tuberculosis , 2007, Emerging infectious diseases.
[21] G. Newton,et al. Association of mycothiol with protection of Mycobacterium tuberculosis from toxic oxidants and antibiotics , 2003, Molecular microbiology.
[22] A. Quémard,et al. Mycolic acid synthesis: a target for ethionamide in mycobacteria? , 1992, Antimicrobial Agents and Chemotherapy.
[23] W. Jacobs,et al. Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis. , 2002, Microbiology.
[24] G. Besra,et al. EthA, a Common Activator of Thiocarbamide-Containing Drugs Acting on Different Mycobacterial Targets , 2007, Antimicrobial Agents and Chemotherapy.
[25] Teresa Quitugua,et al. Single Nucleotide Polymorphisms in Genes Associated with Isoniazid Resistance in Mycobacterium tuberculosis , 2003, Antimicrobial Agents and Chemotherapy.
[26] F. Winder,et al. Effects of ethionamide and isoxyl on mycolic acid synthesis in Mycobacterium tuberculosis BCG. , 1971, Journal of general microbiology.
[27] Morten Nielsen,et al. CPH MODELS 2.0: X3M A COMPUTER PROGRAM TO EXTRACT 3D MODELS , 2002 .
[28] Dipti Sareen,et al. Mycothiol Is Essential for Growth of Mycobacterium tuberculosis Erdman , 2003, Journal of bacteriology.
[29] K. Takayama,et al. Effect of Isoniazid on the In Vivo Mycolic Acid Synthesis, Cell Growth, and Viability of Mycobacterium tuberculosis , 1972, Antimicrobial Agents and Chemotherapy.
[30] C. Locht,et al. Activation of the pro-drug ethionamide is regulated in mycobacteria. , 2000, The Journal of biological chemistry.
[31] James C. Sacchettini,et al. Mechanism of thioamide drug action against tuberculosis and leprosy , 2007, The Journal of experimental medicine.
[32] H. Marrakchi,et al. InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II. , 2000, Microbiology.
[33] W. Jacobs,et al. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. , 1994, Science.
[34] Mehran Hosseini,et al. Global incidence of multidrug-resistant tuberculosis. , 2006, The Journal of infectious diseases.
[35] J. Sacchettini,et al. Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis , 1995, Science.
[36] J. Davies,et al. Distribution of thiols in microorganisms: mycothiol is a major thiol in most actinomycetes , 1996, Journal of bacteriology.
[37] G. Bennett,et al. Metabolic engineering through cofactor manipulation and its effects on metabolic flux redistribution in Escherichia coli. , 2002, Metabolic engineering.
[38] M. Donald Cave,et al. Population Genetics Study of Isoniazid Resistance Mutations and Evolution of Multidrug-Resistant Mycobacterium tuberculosis , 2006, Antimicrobial Agents and Chemotherapy.
[39] Catherine Vilchèze,et al. The mechanism of isoniazid killing: clarity through the scope of genetics. , 2007, Annual review of microbiology.
[40] C. Vilchèze,et al. Altered NADH/NAD+ Ratio Mediates Coresistance to Isoniazid and Ethionamide in Mycobacteria , 2005, Antimicrobial Agents and Chemotherapy.
[41] Neel R Gandhi,et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa , 2006, The Lancet.
[42] M. Rawat,et al. Comparative analysis of mutants in the mycothiol biosynthesis pathway in Mycobacterium smegmatis. , 2007, Biochemical and biophysical research communications.
[43] J. T. Crawford,et al. ethA, inhA, and katG Loci of Ethionamide-Resistant Clinical Mycobacterium tuberculosis Isolates , 2003, Antimicrobial Agents and Chemotherapy.
[44] J. Sacchettini,et al. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. , 1998, Science.
[45] S. Cole,et al. The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis , 1992, Nature.
[46] R. C. Fahey,et al. The mshA gene encoding the glycosyltransferase of mycothiol biosynthesis is essential in Mycobacterium tuberculosis Erdman. , 2006, FEMS microbiology letters.
[47] G. Newton,et al. Identification of the mycothiol synthase gene (mshD) encoding the acetyltransferase producing mycothiol in actinomycetes , 2002, Archives of Microbiology.
[48] F. Portaels,et al. Multicenter study of MTT and resazurin assays for testing susceptibility to first-line anti-tuberculosis drugs. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[49] G. Besra,et al. Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis , 2002, Molecular microbiology.
[50] F. Winder,et al. Inhibition by isoniazid of synthesis of mycolic acids in Mycobacterium tuberculosis. , 1970, Journal of general microbiology.
[51] G. Newton,et al. Biochemistry of the Initial Steps of Mycothiol Biosynthesis* , 2006, Journal of Biological Chemistry.
[52] J. Blanchard,et al. Structural and Enzymatic Analysis of MshA from Corynebacterium glutamicum , 2008, Journal of Biological Chemistry.
[53] M. Hirata,et al. Screening and Characterization of Mutations in Isoniazid-Resistant Mycobacterium tuberculosis Isolates Obtained in Brazil , 2004, Antimicrobial Agents and Chemotherapy.
[54] N. Brown,et al. Molecular Microbiology , 1998, NATO ASI Series.
[55] C. Vilchèze,et al. Isolation and Analysis of Mycobacterium tuberculosis Mycolic Acids , 2007, Current protocols in microbiology.
[56] G. Newton,et al. A Mycothiol Synthase Mutant of Mycobacterium tuberculosis Has an Altered Thiol-Disulfide Content and Limited Tolerance to Stress , 2006, Journal of bacteriology.